PMC:7105881 / 58370-58559
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1739 | 182-188 | Species | denotes | humans | Tax:9606 |
1741 | 162-178 | Disease | denotes | viral infections | MESH:D001102 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T279 | 162-181 | Disease | denotes | viral infections in | http://purl.obolibrary.org/obo/MONDO_0005108 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T672 | 182-188 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T122 | 162-178 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T311 | 0-189 | Sentence | denotes | It is thus expected that one or several of these promising subunit vaccines can be further processed into clinical trials to confirm their immunogenicity against viral infections in humans. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T971 | 139-153 | BV_15 | denotes | immunogenicity |
T972 | 162-167 | NCBITaxon:10239 | denotes | viral |
T973 | 182-188 | NCBITaxon:9606 | denotes | humans |
T29132 | 139-153 | BV_15 | denotes | immunogenicity |
T1412 | 162-167 | NCBITaxon:10239 | denotes | viral |
T23607 | 182-188 | NCBITaxon:9606 | denotes | humans |